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Abstract

Introduction

In this report we review the current knowledge
on the involvement of the interferon (IFN) system in
the regulation of cell growth and differentiation. We
also summarize our own data which provide evidence
for the strong correlation between IFN-mediated
growth-arrest of transformed cells and the elevated
enzymatic activity of an IFN - induced protein. Similarly, it is demonstrated that elevated levels of IF Ninduced proteins accompany the early phases of in vitro cell differentiation. IFN - treatment of NIH/ 3T3
mouse fibroblasts transformed by Moloney-murine
sarcoma virus ( MSV) resulted in a significant reduc tion in the rates of cell growth, protein synthesis
and cloning efficiency. In parallel, 2-5A-synthetase
activity was induced ten - fold above the background
level. Treatment of these cells for 3 days with 450
international units ( lU) / ml of IF N followed by its
removal, resulted in a gradual increase in all parameters associated with cell growth while the 2-5Asynthetase activity was reduced to its normal level.
However, almost no recovery occurred when cells
were treated with 1,800 IU/ml. In parallel, 2-5Asynthetase activity remained highly elevated even at
3 days after the removal of IFN. In these cells, the
expression of both c-myc and v-mos was reduced
rapidly following IFN treatment. Upon removal of
IFN after 24 h of treatment, the expression of both
genes was resumed but with a different kinetics,
suggesting that different mechanisms are responsible
for the reduction in gene expression. In rat skeletal
muscle cultures which differentiate to form myotubes,
the level of both 2-5A-synthetase and protein kinase
activities was transiently elevated, reaching a peak
at 3 days followed by a decrease to background
levels. This peak activity precedes the appearance
of the major muscle differentiating proteins.

Interferon (IFN) is now well known as a general regulatory molecule which participates in a variety
of biological processes within an organism. Increasing evidence suggests that one of the most important
functions of IFN regulation concerns the growth and
differentiation of different cell systems [Clemens,
McNurlan, 1985; Moritz, Kirchner , 1986]. It has been
established that the progression of the cell from the
stationary phase (G 0 ) through the cell cycle is
associated with the activation of certain genes [ Kelly
et al., 1983; Cochran et al., 1984 ; Greenberg, Ziff,
1984; Bravo et al., 1985]. On the other hand, cell
differentiation is accompanied in many cases by the
repression of gene expression [Westin et al., 1982;
Einat et al., 1985]. The possible involvement of IFN
in the regulation of gene expression is not clear, but
it has been demonstrated that in some hematopoietic
cell systems, IFN is produced in an autocrine manner
following induction of differentiation and one of the
major IFN-induced proteins - ( 2 '-5 ' )oligoadenylate
synthetase (2-5A-synthetase), is induce during the
process [Kimchi, 1981; Friedman-Einat et al., 1982;
Yarden et al., 1984; Resnitzky et al., 1986]. The
induction is abolished when the cells are incubated
with antibodies directed against beta-IFN [Kimchi,
1981; Friedman-Einat et al., 1982]. Moreover, 2-5Asynthetase gene expression is induced in quiescent
cells stimulated to grow with a variety of growth
factors [ Lin et al., 1983; Wells, Mallucci, 1985; Zulla
etal., 1985; Garcia-Blanco et al., 1989]. In addition,
IFN has been shown to inhibit the expression of certain oncogenes, c-myc in particular, in some treated
cells [Jonak, Knight, 1984; Einat et al., 1985;
Emanoil-Ravier et al., 1985]. Thus, it is tempting to
postulate that at least some of the regulatory func tions attributed to IFN is mediated through IFN-induced enzymes, generally referred to as the IFN system, such as 2-5A-synthetase, 2-5A activated RNase
[Jacobsen et al., 1983; Krause et al., 1985], and the
double-stranded activated protein kinase [ Galabru,
Hovanessian, 1985]. The first catalyzes the synthesis
of oligomers of adenylic acid in the 2' -5' phosphodiester bond [Kerr, Brown, 1978] which activates a latent endonuclease responsible for the degradation of
messenger and ribosomal RNA molecules [Williams et
al., 197 8; Hovanessian et al., 1979; Wreschner et al.,
1981]. Activation of the 2-5A system and protein
kinase may, therefore, directly cause inhibition of
protein synthesis [Kerr, Brown, 1978; Williams et al.,
1978] as manifested by antiproliferative effects.
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Indeed, IFN has been shown to inhibit the growth of
murine sarcoma virus ( MSV)-transformed cells
[Bakhanashvili et al., 1983]. In addition, it causes
the reversion of the transformed phenotype of cells
transformed by retroviruses [ Hicks et al., 1981] or by
an activated oncogene [ Sam id et al., 1984] . It has
also been demonstrated that 2-5A-synthetase activity
is induced to a much greater level in the transformed cells than in their normal counterpart
[Bakhanashvili et al., 1983; David et al., 1989].
Furthermore, the activity of both enzymes appears to
correlate in certain cases with both the antiviral and
the antiproliferative effects of IFN [Bakhanashvili et
al., 1983; Samuel et al., 1984; Rice et al., 1985;
Resnitzky et al., 1986; Chebath et al., 1987b]. It is,
thus, obvious that in order to elucidate the role of
IFN in the regulation of growth and differentiation,
the involvement of the IFN system in these processes
should be demonstrated and studied.
Skeletal muscle cultures provide a unique system
for the study of morphological and biochemical differentiation.
Primary myoblasts can be prepared
from the embryonic tissues of a variety of species.
With time in culture, the myoblasts fuse to form
multinucleated myotubes which later contract spontaneously, a characteristic of differentiated muscle
fibers. This event is accompanied by the synthesis
of muscle-specific proteins, increase in acetylcholinesterase activity, the appearance of acetylcholine receptor molecules [Fambrough, Rash, 1971;
Shainberg et al., 1984; Buckingham, 1977; Shainberg,
Brik, 1978], and a decrease in DNA polymerase
activity and in DNA synthesis.
The demonstration that the IFN system is activated during the process of muscle differentiation as
well as during the arrest of tumor cell growth is es sential for understanding the role of the system in
the regulation of basic physiological processes within
the organism. Our data provide evidence for these
phenomena and is presented as part of an overview
on the involvement of the IFN system in cell growth
and differentiation as discussed at the Scanning
Microscopy meetings during May 1989 at Salt Lake
City, Utah.
Materials and Methods
Cell cultures
N1H / 3T 3 mouse fibroblasts transformed by and
producing the Moloney strains of MSV and murine
leukemia virus (strain 124) [NIH/3T3(MSV) cells]
were used throughout this study. Occasionally, we
also used the TB cell line (clone 124) producing the
same viral complex [Ball et al., 1973] with identical
results.
The cells were maintained in Dulbecco's
modified Eagle medium supplemented with 10% newborn calf serum (Biological Industries, Beit Haemek,
Israel). The cultures were subdivided every 3-4 days
into 9 cm tissue culture dishes (Nunc, Roskilde, Denmark) and kept at 37°C in a humidified incubator
flushed with 10% CO2. Rat skeletal muscle cultures
were prepared essentially as previously described
[Shainberg et al., 1984]. In all experiments with
IFN, the serum concentration was reduced to 2 .5 %.
Interferon
Mouse beta interferon was used in this study.
It was supplied by Lee Biomolecular ( San Diego, CA)
with a specific activity of 5 .6x107 international units
(IU) per mg protein (cat. No. 20171).

Determination of growth rate
About 5xlo4 cells were seeded in 3 .5 cm tissue
culture dishes ( Nunc, Roskilde, Denmark). A few
hours after seeding, when the cells were attached to
the dish, the medium was replaced with fresh medium
containing various concentrations of IFN. At the indicated times after treatment, the cells were removed
by trypsin, stained with 0.5% trypan blue (in PBS)
and the number of viable cells was determined.
Determination of the rate of protein synthesis
Cells were seeded and treated with IFN as
described above.
At the indicated times after
treatment, the medium was removed and 1 ml/ dish of
fresh medium (containing no serum) supplemented
with 0.25 micro-Ci of -:ltt-leucine (130 Ci/mmol;
Amersham International, Amersham, UK) was added.
After incubation for 3 h at 37°C, the medium was
removed, cultures were washed 3 times with cold
PBS, and the cells were lysed with 1 ml of O.5%
sodium dodecyl sulfate. Acid-insoluble material was
precipitated with 10 % cold trichloroacetic acid and
the precipitate was collected on glass-fiber filters.
The filters were dried, immersed in a toluene-based
scintillation liquid and counted.
Determination of cloning efficiency
The cultures were treated with IFN as described
above. At the indicated times after treatment, cells
were removed, counted and reseeded in 5 cm dishes
at 100 cells per dish in IFN-free medium. After 1014 days, the cultures were fixed with methanol,
stained with Giemsa stain and the number of clones
was determined.
Recovery from the IFN effect
Cultures were treated with the indicated IFN
concentration, as described above, for 72 h. The
cells were then removed with trypsin, washed 4 times
with PBS, reseeded at 5xlo4 cells per 3 .5 cm dish or
at 5x105 cells per 10 cm dish (for the determination
of 2-5A-synthetase activity), and subdivided into two
groups. One group received IF N-free medium, while
the other received medium containing identical concentrations of IFN used during the first 72 h. All
parameters were then determined as described above.
Preparation of cell extracts (SlO)
Cell extracts were prepared after the appropriate treatment by removing the cultured cells with a
rubber policeman in PBS. The cells were then centrifuged at 800x g for 5 min, washed twice with cold
PBS and resuspended for 10 min in an ice-cold lysis
buffer (buffer A) containing 20mM Hepes pH 7.5,
5mM Mg-Acetate, 0 .5 % NP-40, lmM dithiothreitol,
10% glycerol and 1 mM EDTA. The extracts were
centrifuged at 10,000x g for 10 min and the soluble
fractions (SlO) were stored at -70°C until use.
Determination of 2-5A synthetase activity
The activity of 2-5A -synthetase in cell extracts
(SlO) was performed as previously described [Chebath
et al., 1987a] with 20 microgram protein in the presence of 50 microgram/ml of poly(!) .poly(C) (Pharmacia, Uppsala, Sweden). In some cases, the extracts
were first incubated with poly(!) .poly(C) agarose
beads (Pharmacia), washed and then assayed for 25A-synthetase activity. The same results were obtained. Hence, the "in solution" method was routine ly used. The 32P-labeled 2-5A oligomers were analyzed by high voltage electrophoresis [ Chebath et al.,
1987a].
The radioactive spots were detected by
autoradiography and the amount of radioactivity in
each spot was determined by immersing the dried
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spots in toluene-based scintillation fluid. The results
are presented as pmoles of ATP polymerized based on
the radioactivity obtained with a known amount of
a- 32p-ATP placed on 3mm paper discs.
Two methods were used for the size determination of 2-5A oligomers formed in the enzymatic
assay. First, a mixture of 0 .05 units of authentic
core forms of 2-5A dimers, trimers and tetramers
(Pharmacia) were analyzed in parallel in each experiment and the spots identified by illumination with a
UVSL-25 lamp.
In addition, we always used as a
positive control cell extracts prepared from IFNtreated NIH/3T3 (MSV) cells. Such extracts contain
a high level of active 2-5A synthetase which yields
whole series of oligomers.
Determination of protein kinase activity
Cell extracts (Sl0) were prepared as described
above. Heparin (50-100 units/ml) was added to cell
extract samples each containing 500 microgram of
protein. The mixtures were incubated at 4°C for 10
min. An equal volume of poly( I) .poly(C)-Sepharose
beads (Pharmacia) was added at room temperature for
30 min with occasional gentle mixing.
The beads
were washed several times with buffer B containing
10 mM Hepes pH 7 .6, 50 mM KCl, 2 mM Mg-acetate,
7 mM 2-B-mercaptoethanol, 20% glycerol, and then
one in buffer C (buffer B supplemented with 5 mM
MnCl2). The final pellet was resuspended in buffer
C supplemented with 1 micro-Ci y_32P-ATP (50-100
Ci/mmol; New England Nuclear, Boston, MA) and incubated for 90 min at 30°C. After centrifugation,
the pellet was washed 3 times with buffer C and
resuspended in 2 / 3 volume of buffer C and 1 / 3 volume of electrophoresis sample buffer containing 6 %
SDS (w/v), 30% glycerol (v/v), 0.02% bromophenol
blue (w /v ), 200 mM Tris-HCl, pH 6.8 and 250 mM Bmercaptoethanol. The samples were then heated at
95°C for 5 min and centrifuged. The supernatants
were collected and analyzed on 10% polyacrylamide
slab gels containing SDS. The phosphorylated proteins were detected by autoradiography on Kodak
XAR-5 film.
DNA probes
The probe for c-myc was a 2.9 kbp BamHI fragment that contained the gag and myc specific sequence of the MC29 viral genome subcloned in
pBR322 [Reddy et al., 1983). The insert DNA was
cleaved by BamHI under conditions recommended by
the manufacturer (New England Biolabs, Beverly, MA)
and purified by agarose gel electrophoresis, electroelution, and further purification on Elutip-D columns
(Schleicher and Schull, Dassel, W. Germany). The
probe for detecting v-mos transcripts was a 2 .5 kbp
EcoRI fragment of human DNA which shares a 0 .65
kbp region of continuous homology with v-mos. This
fragment was also cloned in pBR322 [Prakash et al.,
1982). The insert was cleaved by EcoRI and purified
as mentioned above.
All the probes were nicktranslated as previously described [Rigby et al., 1977)
to a specific activity of lx108 cpm/microgram using
32P-dCTP (specific activity - 800 Ci/mmol; New England Nuclear, Boston, MA) as the labeled precursor.
RNA preparations and hybridization
Total RNA from confluent cultures, either untreated or treated with IFN as indicated for each
experiment, was purified by LiCl-urea precipitation
and phenole -c hloroform extraction as previously described [Auffray, Rougeon, 1980). Poly (A)+-containing molecules were isolated by passing the RNA
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preparation through oligo(dT) -c ellulose columns
[Maniatis et al., 1982).
For slot-blot analysis,
samples containing the appropriate amounts of
poly (A)+ RNA were diluted in 15xSCC (lxSSC = 0.lM
NaCl; 0.0lM Na citrate), heated at 65°C for 15 min
and applied to nitrocellulose membrane filters
(Schleicher and Schuell) presoaked in l0xSSC. The
filters were washed with 2xSSC, dried and baked at
80°C for 2 h in a vacuum.
For hybridization, the nitrocellulose filters were
first prehybridized overnight at 42°C in a solution
containing 50% formamide, 5xSSC, 0.1% SDS, 2 .25 mM
Na4P2O7.l0H2O, 5xDenhart's (lxDenhart's = 0.02%
Ficoll, 0.02% polyvinyl pyrrolidone, 0.02% bovine
serum albumin) and 250 microgram/ml of denatured
salmon sperm DNA. Hybridization was performed at
42°C for 24 h in the same buffer containing lx106
cpm /ml of 32p -labeled probe.
Results
Susceptibility of NIH/3T3(MSV) cells to growth
mh1b1tion by IFN
NIH/3T3(MSV) cells are highly susceptible to
growth inhibition by IFN [ Bakhanashvili et al., 1983).
Furthermore, in these cells, both the expression and
activity of 2 -5A-synthetase are induced to a significant level following IFN-treatment [Bakhanashvili et
al., 1983; David et al., 1989) . We therefore reasoned
that these cells may serve as a useful model for
studies on the involvement of the IFN system in the
regulation of cell growth. A typical result of the
effect of mouse beta-lFN on the growth characteristics of NIH/3T3(MSV) cells is shown in Fig. 1. In
agreement with our earlier findings [ Bakhanashvili et
al., 1983), it is clearly demonstrated that a significant inhibition of growth in a dose dependent manner is observed in our experimental system. These
cells were thus used for further analysis.
IF N -induced antiproliferative and 2-5A-synthetase
activ1ties
Smee we are attempting to establish the involvement of the IFN system in the manifestation of
the antiproliferative property of IFN, it was of interest to follow the kinetics of both the growth and
the 2-5A-synthetase activity after removal of IFN
from the culture medium of NIH/3T3(MSV) cells. It
is argued that as long as the enzymatic activity remains elevated, the cells will continue to exhibit
growth arrest.
Transformed cultures were, therefore, treated
with IFN at various concentrations for 72 h. The
cells were then removed, replated and divided into
two groups. One group received IFN at the same
concentrations while the other was refed with IFNfree medium. The rates of cell growth and protein
synthesis were then determined. As illustrated in
Fig. 2, treatment with IFN at low concentrations
(90-450 IU/ml) for 72 h resulted in almost full recovery of the treated cells following removal of IFN.
However, as the IFN concentration increased, the
recovery was less evident and at 1200-1800 IU/ml,
there was almost no recovery, with the kinetics of
both cell growth and protein synthesis identical in
continuously IFN-treated cultures and in cultures
treated with IFN for 72 h only.
Similar conclusions can be drawn from the results on the cloning efficiency of treated cultures
summarized in Fig. 3. The cloning efficiency of cells
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Figure 1: Phase contrast micrographs of effect of IFN on NIH/3T 3 (MSV) cultures. (A) Control untreated
cultures. Cultures were treated for 3 days with IFN at the following concentrations: (B) 400IU /m l; (C)
800IU /ml; and (D) 1, 200IU /ml.

treated for 72 h with IFN at 1800 IU / ml and grown
further in IFN - free medium for another 72 h was
close to that of cells continuously treated with IFN.
However, since all cells were cloned in the absence
of IFN, partial recovery was detected even in cultures treated for the first 72 h with 1200 IU/ml of
IFN. Furthermore, it appeared that the fraction of
cells among the entire cell population capable of
producing clones remained stable after 72 h treatment with IFN, even when the cultures were treated
with IFN for an additional 72 h.
It should be emphasized that in several experiments cultures were treated continuously with IFN
for 96 h without being subdivided. Here again, max imum activity was seen at 72 h after treatment, and
the same level of inhibition was observed at 96 h
(unpublished data). However, the cells tended to detach from the plate's surface as incubation proceeded. Therefore, the subdivision procedure described
above was used in most experiments.
Next, the kinetics of 2-5A-synthetase activity
was determined under similar experimental conditions.
Cells were treated with either 450 or 1800 IU/ml of
IFN for 72 h, then subdivided into two sets. One
set received IFN at the same concentration, and the

other was fed with IFN - free medium. The activity
of 2-5A-synthetase was determined at daily intervals
thereafter. The results shown in Fig. 4 clearly dem onstrate that the enzymatic activity in continuously
treated cultures remained high throughout the entire
incubation period in both IFN concentrations used.
However, in cells treated with IFN for only 3 days,
the level of 2-5A activity was reduced to its normal
level following treatment with 450 IU/ml, where the
level of the enzymatic activity remains high , al though IFN is no longer present in the culture medi um. These results correlate well with the data on
the recovery from the IF N-induced antiproliferative
effect described above (see Fig. 2).
The IF N effect and oncogene expression
The protooncogene c -myc is a cell cycle associated gene shown to be expressed during stimulated
cell growth [Kelly et al., 1983] and, when constitutively activated, to block cell differentiation
[Coppola, Cole, 1986; Dmitrovsky et al., 1986;
Freytag, 1988]. The viral oncogene v-mos is the
transforming gene of M-MSV [Blair et al., 1984].
Since in a preliminary experiment we observed that
IFN affects the cell cycle distribution of NIH/3T3
(MSV) cells (data not shown) and because these cells
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Activation of the IFN system during myogenesis
Terminal differentiation is associated with
growth arrest of the differentiated cells. We showed
that the level of 2-5A-synthetase activity correlates
well with the antiproliferative activity of IFN.
Therefore, it was now important to clarify whether
the IFN system is also activated during the differentiation process.
Myoblasts obtained from rat, mouse, or chick
embryonic muscle provide a unique model for the
study of differentiation. Within a week after seeding, these cells fuse to form myotubes, which contract spontaneously while synthesizing muscle specific
proteins. In order to study the involvement of the
IFN system in myogenesis, rat embryonic muscle cultures were prepared and, at daily intervals after
seeding, 2-5A-synthetase activity was determined in
cell extracts. The enzymatic products included the
various 2 -5A oligomers formed in the assay. These
were separated by high-voltage electrophoresis, and
the radioactive spots were identified by autoradiography. The results are demonstrated in the inset to
Fig. 6.
The scanning analysis of the radioactive
spots is illustrated in the major section of Fig. 6
which shows that 2-5A-synthetase activity was transiently elevated during myogenesis.
After a low
basal level on the first day in culture there was a
gradual increase to a peak activity on the third day
and a decline on the following days. The major enzymatic product detected in muscle cell extracts was
the trimer form of 2-5A, although traces of the
dimer form could also be observed. The same result
was obtained with muscle cell extracts from the
other animal species used in this study. In contrast,
a series of oligomers was observed with cell extracts
prepared from IFN-treated NIH/3T3(MSV) cells which
served as a marker (Fig. 6 inset, right column).
Next, we decided to determine the kinetics of
the activity of double-stranded activated protein
kinase, a well known and characterized IFN-induced
protein [ Galabru et al., 1984; Galabru, Hovanessian,
1985]. Similar kinetics to that observed with 2-5Asynthetase will support the assumption that several
proteins known to be induced by IFN are elevated in
a characteristic manner during the differentiation of
skeletal muscle cultures.
Cell extracts were prepared at daily intervals
after seeding and the protein kinase activity was assayed in each extract. In Fig. 7, the appearance of
the major phosphorylated protein, P68, most likely
the enzyme molecule itself [ Galabru, Hovanessian,
1985], is shown in the inset and its tracing registered by a scanning densitometer is demonstrated in
the main part of the figure. Similar to the pattern
observed with 2-5A-synthetase, the activity of protein kinase was transiently elevated in rat skeletal
muscle cultures, reaching a peak activity on the
third day in culture.
Discussion
The mechanism involved in the antiproliferative
effect of IFN is still not completely understood.
However, since the antiviral property of IFN appears
to be mediated through proteins induced in IFN treated cells [Baglioni, 1979], it is tempting to postulate that most biological effects of IF N are also
mediated through similar sets of proteins. Indeed,
published data demonstrate a correlation between the

sensitivity of cell growth to IFN and the inducibility
of 2-5A-synthetase by IFN in these cells [Czarniecki
et al., 1981; Kimchi, 1981], although some reports do
not always support this conclusion [Vandenbussche et
al.,1981].
There is no doubt that various types of cells
differ in their sensitivity to IFN and in the inducibility of 2-5A-synthetase, indicating that IFN acts
through various mechanisms [Esteban, Paez, 1985].
However, in a few cell lines derived from NIH/3T3
mouse fibroblasts, a defect detected in the 2-5A-system was responsible for the resistance of the cells
to, at least, the IFN-induced antiviral effect [Epstein
et al., 1981; Salzberg et al., 1983]. We have demonstrated that a few MSV-transformed mouse fibroblast
clones possess an unusually high basal level of 2-5Asynthetase activity. These cells are relatively re sistant to cytolytic viral infection even in the absence of IFN [David et al., 1989). Hence, it seems
important to establish whether it is possible to attribute an essential role to an IFN-induced enzyme in
its antiproliferative effect as well. In the present
study, a correlation between the level of 2-5A-synthetase activity and the antiproliferative effect mani fested by IFN on MSV-transformed NIH/3T3 cells was
demonstrated. IFN strongly inhibited the growth of
the transformed cells in a dose-dependent manner,
while 2-5A-synthetase activity was induced to a significantly high level under the same experimental
conditions. Furthermore, we demonstrated for the
first time that as long as the activity of this enzyme
is not reduced following the removal of IFN from the
culture medium (e.e., with 1800 IU /ml), the antiproliferative effect of IFN remains constant. However,
when lower IFN concentrations were used ( 450 IU /
ml), recovery was clearly observed, and this was accompanied by a reduction in 2-5A-synthetase activity.
The role of the 2-5A system in the development
of the antiproliferative effect is not clear. Certainly, 2-5A-synthetase could be just one of a variety of
factors, including IFN-induced protein kinase
[ Galabru, Hovanessian, 1985), which may function
during this process and lead to the regulation of
gene expression.
The protooncogene c -myc has been shown to be
involved in differentiation and growth arrest in
several cell systems [ Gonda, Metcalf, 1984; Lachman,
Shoulchi, 1984; Dean et al., 1986; Siebenlist et al.,
1988). During these processes, c-myc expression is
reduced, apparently by a two-step mechanism leading
to an initial post-transcriptional block which is
followed by inhibition of c -myc transcription
[Siebenlist et al., 1988]. On the other hand, c-myc
as well as other nuclear protooncogenes are tran siently activated when cells are induced to proliferate [Campisi et al., 1984; Cochran et al., 1984;
Greenberg et al., 1985; Kelly et al., 1983]. It is,
thus, obvious that the level of expression of c-myc
is an indication of the availability of the cell for
replication.
This fact is supported by our data
which demonstrate that, in NIH/3T3(MSV) cells, IFNtreatment results in a rapid reduction in the expression of c-myc. In this respect, these cells behave
similarly to those of other IFN-sensitive cell lines,
particularly Daudi cells, which have also shown a
reduction in c - myc expression following IFN treatment [Einat et al., 1985; Jonak, Knight, 1984; Dani et
al., 1985).
V-mos is the transforming oncogene of M-MSV

485

S. Salzberg, D. Hacohen, S. David
[Blair et al., 1984], and its expression is driven by
the viral promoter present in the viral long terminal
repeat. Therefore, this expression may be regulated
by a different mechanism than cellular genes.
At least two possibilities are immediately feasible in explaining the mechanism involved in the inhibition of c-myc or v-mos expression by IFN in our
experimental system. First, a shut-off of the transcription machinery is apparently a target of IFN
action, as has been shown by Einat and colleagues
[Einat et al., 1985]. However, a post-transcriptional
control, which affects the stability of RNA transcripts rather than the transcription rate, must also
be considered, especially since such a mechanism of
IF N-action has been reported [Jonak, Knight, 198 4;
Dani et al., 198 5] . Finally, a more complex mechanism which combines both possibilities cannot be
ruled out.
For example, one can argue that IFN
first causes pretermination of transcription at the
non -coding sequence of the first myc axon [ Nepveu,
Marcu, 1986], and only then a block in the transcription process itself. However, in our experimental system there was a difference in the kinetics of
reappearance of c -myc and of v-mos transcripts upon
removal of IFN. In the case of c-myc, a gradual increase in the level of mRNA specific molecules was
observed, which, we suggest, is an indication of the
resumption of the transcription activity that is
blocked in the presence of IFN. However, in the
case of v-mos, an immediate increase in the level of
RNA transcripts was evident, followed by a decrease
toward control levels. One possible explanation for
this phenomenon is that IFN affects the stability of
this type of transcript only but does not interfere
with the binding of DNA polymerase to the gene
promoter. When the block is removed, mRNA molecules are immediately available in great abundance,
as active transcription never ceases. This is fol lowed by a stabilization step concomitant with the
reappearance of a regular cell phenotype.
It has been shown that IFN stimulates various
morphologic and biochemical changes in several cell
systems. The best examples studied thus far are the
hematopoietic cell systems [Rossi et al., 1980; Tomida
et al., 1982; Fisher et al., 1983; Hattori et al., 1983;
Harris et al., 1985]. Indeed it has been demonstrated
that IFN is released in an autocrine fashion in some
hematopoietic cells induced to differentiate with the
appropriate agents [Kimchi, 1981; Friedman-Einat et
al., 1982; Yardenet al., 1984; Resnitzky et al., 1986].
This release is reflected by an elevated level of 25A-synthetase activity, an indication that the IFN
system may be involved in the differentiation proc ess , as suggested by Chebath and colleagues (1986].
Our results show that the possible involvement
of the IFN system in the differentiation process is
not limited to certain hematopoietic cells, but that it
may have a much wider significance. We have clearly shown that the activity of both 2 -5A-synthetase
and double-stranded RNA-activated protein kinase increase transiently in muscle primary cell extracts,
reaching a peak activity at 3 days in culture, at the
onset of the fusion process. The enzymatic activities
appear to have similar kinetics in cultures derived
from three different species (data not shown) and
seem to precede the appearance of muscle specific
proteins, particularly in the case of rat-derived cell
cultures. Although it is certainly possible that this
similarity in kinetics is coincidental and that these

enzymes have no functional role in myogenesis, it is
reasonable to consider that the IFN system may play
an important role in the initiation of the differentiation process. This hypothesis is strengthened by the
fact that the enzymatic product of 2-5A-synthetase
present in myoblasts is the trimer form of 2-5A,
which is unique and may reflect an activity of a
more specialized enzyme. Indeed, various forms of
2-5A-synthetase have been detected in IFN-treated
cells [Chebath et al., 1987a]. Another indication of
the importance of the IFN system is the fact that
the enzymatic activities of both 2-5A-synthetase and
protein kinase are reduced to basal levels in fully
differentiated myotubes, indicating that these enzymes are no longer needed at this stage of the differentiation process. An identical trimer form of 25A with similar kinetics was observed during chondriogenesis in vivo [Maor et al., in preparation].
The exact role that the IFN system may fulfill
during differentiation remains unclear. However, it
is evident that nuclear protooncogenes, particularly
c -myc, are essential for cell-growth and are switched
off during the differentiation of several cell systems,
including hematopoietic cells [ Gonda, Metcalf, 1984;
Lachman, Shoulchi, 1984]. In some cases, for example in the murine embryonal carcinoma cell line F9
induced to differentiate with retinoic acid and cyclic
AMP, the expression of c -myc is regulated post transcriptionally [Dean et al., 1986]. One interpretation is that the stability of c -myc mRNA tran scripts is reduced in this system, which could certainly be the result of nuclease activity induced by
2-5A oligomers, the enzymatic products of 2-5Asynthetase [Baglioni, 1979]. The reduction in c-myc
expression has been demonstrated also during differentiation of myoblasts [Olson et al., 1987], and
therefore a similar mechanism in these cells is
possible.
Based on the results of this study, we suggest
that the IFN system may be involved in the differentiation process of cells of various lineages and may
indeed be crucial for the normal progression of dif ferentiation. An altered expression of the IFN system or a lack of response to its signals may therefore lead to the development of malignancy. However, more direct proof is needed before the role of
the IFN system in myogenesis can be established
unambiguously.
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B. Silverman:
What is the rationale for adding
heparm to the protein kinase assays? Hovanessian
showed that heparin activates the kinase.
Authors:
Heparin inhibits the activity of most
protem kinases not related to the IFN-effect.
J. Chebath:

Did you determine the levels of c -myc
and v-mos expression in cells treated for 3 days by
1800 U/ml of IFN?
Authors : The recovery of c-myc and v-mos expression after IFN-removal was studied on cultures
treated for 24 h only with IFN. We are planning to
perform a more detailed analysis on the recovery of
cells treated for extended periods of time with
different concentrations of IFN.

Discussion with Reviewers
P.M. Grimley: How specifically does your data contribute to a better understanding of the effects of
interferon on differentiation? For example, the adipocyte model has already been examined in consider able detail by Grossberg et al. In view of previous
data, how can you postulate a significant role of 25A-synthetase, since you did not assay for RNAase
or ribosomal cleavage activity in your experiments?
Authors : The discussion brings data that support the
hypothesis that the activation of the IFN system
occurs both in IFN-growth arrested cells and during
terminal differentiation. In both cases, cells enter
the G0 phase in the cell cycle. It is true that these
findings are only correlative and may be fortuitous.
Also, we point out that in different differentiating
systems like myogenesis or chondriogenesis, the ap pearance of 2-5A - synthetase or protein kinase activ ities occur in a specific manner. Certainly, only
when specific inhibitors for 2- 5A - synthetase or antisense RNA will be available, a more direct approach
c a n be utilized.

J. Chebath:
Did you try to identify further the
radioactive oligomers of ATP formed in the muscle
cell extracts in the course of differentiation as
authentic 2-5A trimer?
Authors: We used two sets of markers for the identification of the 2-5A oligomers, including authentic
molecules. We believe that those markers are sufficient to positively identify the enzymatic products ,
particularly when the experiments were performed at
least 6 times with identical results.

489

